Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: J Control Release. 2023 May 27;358:729–738. doi: 10.1016/j.jconrel.2023.05.029

Fig. 6.

Fig. 6.

Total Doxil® accumulation in plasma and tumor tissue. Doxil® was administered 24 h after a 1× PBS. 1 μg IFN-λ, or 10 μg IFN-λ pretreatment injection in Balb/c female mice. Accumulation was measured 24 h after Doxil® injection. X-axis represents the pretreatment that the mice received. A t-test with Welch’s correction was used to determine if IFN-λ pretreatment showed statistically significant differences in accumulation when compared to PBS. Statistically significant differences are represented with asterisks (* = p ≤ 0.05) (A. – B.: n = 4).